Bondronat 2 mg/2 ml Concentrato per soluzione per Infusione

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

buyitnow

PIL PIL (PIL)
15-05-2024
SPC SPC (SPC)
15-05-2024

active_ingredient:

acido ibandronicum

MAH:

Atnahs Pharma Switzerland AG

ATC_code:

M05BA06

INN:

acid ibandronicum

pharmaceutical_form:

Concentrato per soluzione per Infusione

composition:

acidum ibandronicum 2.0 mg ut natrii ibandronas monohydricus, natrii chloridum corresp. acidum aceticum glaciale, natrii acetas trihydricus, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 6.98 mg.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Tumorinduzierte Ipercalcemia

authorization_status:

zugelassen

authorization_date:

1997-12-22

documents_in_other_languages

SPC SPC գերմաներեն 24-10-2018
PIL PIL ֆրանսերեն 15-05-2024
SPC SPC ֆրանսերեն 23-10-2018